Obinutuzumab T9924
Specifications
| 1mg/5mg/10mg/25mg/50mg/100mg |
Bioactivity:
Obinutuzumab GA101) a novel glycoengineered Type II CD20 monoclonal antibody in development for non-Hodgkin lymphoma.
CAS nr:
949142-50-1
Purity:
98%
Molecular Weight:
SMILES:
Formula:
Pathway:
Others
Target:
Others
